Physician profile
Mary-Cate Devitt
NPI 1790267466
$3,442.76
in general payments reported to CMS, 2019-2025
11 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,117 · 2023: $1,255 · 2024: $759 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,325.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $1,544.93 | 2022-2024 | |
| Abbott Laboratories | $840.11 | 2023-2025 | Proclaim, Eterna |
| Pacira Pharmaceuticals Incorporated | $292.60 | 2023-2024 | Iovera, Exparel, Zilretta |
| Collegium Pharmaceutical, INC. | $215.69 | 2022-2025 | Belbuca, Xtampza |
| Pfizer INC. | $201.89 | 2023-2025 | |
| Abbvie INC. | $156.04 | 2022-2025 | |
| Depuy Synthes Sales INC. | $56.22 | 2022-2025 | Monovisc, Orthovisc |
| Medtronic, INC. | $53.54 | 2023 | V-Loc 180 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.68 | 2022-2025 | Relistor, Trulance |
| Avanos Medical | $21.87 | 2022 | |
| Curonix LLC | $14.19 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary-Cate Devitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.